Aimei Health Technology (NASDAQ:AFJK) Issues Earnings Results

Aimei Health Technology (NASDAQ:AFJK) posted its earnings results on Tuesday. The company reported $0.01 earnings per share (EPS) for the quarter, FiscalAI reports.

Aimei Health Technology Stock Performance

Shares of NASDAQ AFJK opened at $32.01 on Wednesday. The stock has a 50 day moving average price of $41.60 and a 200 day moving average price of $40.85. Aimei Health Technology has a 52 week low of $6.75 and a 52 week high of $130.37. The stock has a market capitalization of $101.47 million, a PE ratio of 177.83 and a beta of 0.22.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Institutional Trading of Aimei Health Technology

A number of hedge funds have recently made changes to their positions in AFJK. Jane Street Group LLC acquired a new stake in shares of Aimei Health Technology in the fourth quarter valued at approximately $302,000. Dakota Wealth Management acquired a new stake in shares of Aimei Health Technology in the fourth quarter valued at approximately $406,000. Geode Capital Management LLC acquired a new stake in shares of Aimei Health Technology in the fourth quarter valued at approximately $413,000. Clear Street Group Inc. acquired a new stake in shares of Aimei Health Technology in the third quarter valued at approximately $691,000. Finally, Quarry LP lifted its position in shares of Aimei Health Technology by 6.4% in the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after buying an additional 10,000 shares during the last quarter. 45.58% of the stock is owned by institutional investors and hedge funds.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.